Understanding Takhzyro Prescribing Information: A Comprehensive Guide for Patients
Patients dealing with hereditary angioedema (HAE) have been suffering from recurrent episodes of swelling in different parts of the body. It is a rare genetic disorder that affects around 1 in 10,000 to 1 in 50,000 people worldwide. The good news is that there are treatments available to manage the symptoms effectively. One of the newer drugs on the market is Takhzyro. This article presents information about Takhzyro prescribing information for patients, so they understand how it works and what to expect.
What is Takhzyro?
Takhzyro (lanadelumab) is a monoclonal antibody that works by reducing the chances of bradykinin formation. Bradykinin is a chemical in our body that causes swelling. By inhibiting bradykinin, Takhzyro can reduce the frequency and severity of HAE attacks. It is approved by the FDA and is available in the form of a subcutaneous injection.
Who can use Takhzyro?
Takhzyro is suitable for adults and children aged 12 and over to prevent attacks of HAE. It is not intended to treat an active episode of HAE. Patients should be aware of this so that they do not use Takhzyro during an acute attack.
How is Takhzyro prescribed?
Takhzyro is prescribed by a healthcare professional who has experience in managing HAE. The dosage is dependent on the patient’s weight, age, and overall health. Before using Takhzyro, it is essential to read the prescribing information carefully. Patients should be given instructions on how to administer the injection by a healthcare professional.
What are the side effects of Takhzyro?
Like most medications, Takhzyro can have side effects. The most common side effects of Takhzyro include redness, swelling, and pain at the injection site. Other side effects that have been reported include dizziness, fever, and headaches. Patients should report any side effects to their healthcare provider right away.
Conclusion
Takhzyro is a promising treatment option for patients with HAE. It is essential to understand the prescribing information before using the medication. Patients should discuss any questions or concerns with their healthcare provider and follow the instructions for use carefully. By doing so, patients can manage their symptoms of HAE and improve their overall quality of life.
